Results 111 to 120 of about 1,067 (171)
peer reviewedBACKGROUND AND OBJECTIVE: To identify the most responsive and sensitive clinical outcome measures in GNE myopathy. METHODS: ClinBio-GNE is a natural history study in GNE myopathy.
Hogrel, Jean-Yves +14 more
core +1 more source
Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan. [PDF]
Suzuki N +17 more
europepmc +1 more source
GNE myopathy is an autosomal recessive muscular disorder of young adults characterized by progressive skeletal muscle weakness and wasting. It is caused by a mutation in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene, which
Bosch Morató, Mònica, 1986- +7 more
core +1 more source
Background Congenital thrombocytopenia represents a diagnostically challenging group of disorders due to overlapping clinical presentations among various etiologies.Case Presentation A 3-month-old infant presented with severe thrombocytopenia (platelet ...
Omar Ahmed Alshaikhi +1 more
doaj +1 more source
Panchakarma Based Therapeutic Interventions in GNE Myopathy- Insights Through A Case Study
GNE myopathy is a rare autosomal recessive muscular disorder characterized by progressive skeletal muscle atrophy, primarily due to mutations in the GNE gene.
Soundarya Nagappa Satapute +1 more
core +1 more source
Two recurrent mutations are associated with GNE myopathy in the North of Britain
Objective GNE myopathy is a rare recessive myopathy associated with inclusion bodies on muscle biopsy. The clinical phenotype is associated with distal muscle weakness with quadriceps sparing.
Chaouch A +22 more
core
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study. [PDF]
Carrillo N +21 more
europepmc +1 more source
Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy. [PDF]
Van Wart S +4 more
europepmc +1 more source
Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients. [PDF]
Kurashige T +4 more
europepmc +1 more source

